EUVIMEDEUVIMED entdecken
Leserbrief

Oritavancin use in patients with recurrent bone infections by methicillin-resistant Staphylococcus aureus with monitoring of concentrations

Marco Bongiovanni, Paul Thoueille, Beatrice Barda, Thomas Mercier, Catia Marzolini, Niccolò Ramponi, Eva Choong, Marco Cantù, Laurent A Decosterd, Enos Bernasconi

European Journal of Clinical Microbiology & Infectious Diseases · 2024

DOI: 10.1007/s10096-024-04844-5 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Marco Bongiovanni und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland. Marco.Bongiovanni@eoc.ch. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Lipoglycopeptides, Anti-Bacterial Agents, Staphylococcal Infections. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusLipoglycopeptidesAnti-Bacterial AgentsStaphylococcal InfectionsHumansMaleFemaleMiddle AgedRecurrenceAgedDrug MonitoringMicrobial Sensitivity TestsAdultOsteomyelitisVancomycin

Substanzen

LipoglycopeptidesoritavancinAnti-Bacterial AgentsVancomycin

Autor:innen und Institutionen

  • Division of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland. Marco.Bongiovanni@eoc.ch.
  • Division of Infectious Diseases and Hospital Epidermiology, University Hospital Basel, Basel, Switzerland. Marco.Bongiovanni@eoc.ch.
  • Service and Laboratory of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Division of Infectious Diseases and Hospital Epidermiology, University Hospital Basel, Basel, Switzerland.
  • Division of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Istituto di Medicina di Laboratorio EOLAB Ente Ospedaliero Cantonale, Bellinzona, Switzerland.

Zitieren

APA

Bongiovanni, M., Thoueille, P., Barda, B., Mercier, T., Marzolini, C., Ramponi, N., Choong, E., Cantù, M., Decosterd, L. A., & Bernasconi, E. (2024). Oritavancin use in patients with recurrent bone infections by methicillin-resistant Staphylococcus aureus with monitoring of concentrations. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04844-5

Vancouver

Bongiovanni M, Thoueille P, Barda B, Mercier T, Marzolini C, Ramponi N, et al. Oritavancin use in patients with recurrent bone infections by methicillin-resistant Staphylococcus aureus with monitoring of concentrations. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04844-5

BibTeX
@article{Bongiovanni2024,
  author = {Bongiovanni, Marco and Thoueille, Paul and Barda, Beatrice and Mercier, Thomas and Marzolini, Catia and Ramponi, Niccolò and Choong, Eva and Cantù, Marco and Decosterd, Laurent A and Bernasconi, Enos},
  title = {Oritavancin use in patients with recurrent bone infections by methicillin-resistant Staphylococcus aureus with monitoring of concentrations},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  doi = {10.1007/s10096-024-04844-5}
}
Kostenlos starten →